Clinical Trial Update: Checkpoint Inhibitors and SBRT for MCRPC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating checkpoint inhibitors in combination with stereotactic body radiotherapy for metastatic castration-resistant prostate cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Herlev and Gentofte Hospital | Conditions: Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer | Phase 2 | Status: COMPLETED